4.5 Review

New insights into type I interferon and the immunopathogenesis of persistent viral infections

期刊

CURRENT OPINION IN IMMUNOLOGY
卷 34, 期 -, 页码 91-98

出版社

CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2015.03.002

关键词

-

资金

  1. National Institutes of Health (NIH) [AI085043, AI082975, AI109627]
  2. Fonds de la recherche en sante du Quebec

向作者/读者索取更多资源

Most viruses generate potent T cell responses that rapidly control infection. However, certain viruses can subvert the immune response to establish persistent infections. The inability to clear virus induces an immunosuppressive program leading to the sustained expression of many immunoregulatory molecules that down-regulate T cell responses. Further, viral persistence is associated with multiple immune dysfunctions including lymphoid disorganization, defective antigen presentation, aberrant B cell responses and hypergammaglobulinemia. Although best known for its antiviral activity, recent data has highlighted the role of type I IFN (IFN-I) signaling as a central mediator of immunosuppression during viral persistence. It is also becoming increasingly apparent that many of the immune dysfunctions during persistent virus infection can be attributed directly or indirectly to the effects of chronic IFN-I signaling. This review explores the increasingly complex role of IFN-I in the regulation of immunity against persistently replicating virus infections and examines current and potential uses of IFN-I and blockade of IFN-I signaling to dampen chronic inflammation and activation in the clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine

Anne A. Gershon, David Brooks, Donald D. Stevenson, William K. Chin, Michael B. A. Oldstone, Michael D. Gershon

JOURNAL OF INFECTIOUS DISEASES (2019)

Article Oncology

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)

Derek L. Clouthier, Scott C. Lien, S. Y. Cindy Yang, Linh T. Nguyen, Venkata S. K. Manem, Diana Gray, Michael Ryczko, Albiruni R. A. Razak, Jeremy Lewin, Stephanie Lheureux, Ilaria Colombo, Philippe L. Bedard, David Cescon, Anna Spreafico, Marcus O. Butler, Aaron R. Hansen, Raymond W. Jang, Sangeet Ghai, Ilan Weinreb, Valentin Sotov, Ramy Gadalla, Babak Noamani, Mengdi Guo, Sawako Elston, Amanda Giesler, Sevan Hakgor, Haiyan Jiang, Tracy McGaha, David G. Brooks, Benjamin Haibe-Kains, Trevor J. Pugh, Pamela S. Ohashi, Lillian L. Siu

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Review Immunology

Type I interferon signaling, regulation and gene stimulation in chronic virus infection

Sabelo Lukhele, Giselle M. Boukhaled, David G. Brooks

SEMINARS IN IMMUNOLOGY (2019)

Article Oncology

Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials

Ramy Gadalla, Babak Noamani, Bethany L. MacLeod, Russell J. Dickson, Mengdi Guo, Wenxi Xu, Sabelo Lukhele, Heidi J. Elsaesser, Albiruni R. Abdul Razak, Naoto Hirano, Tracy L. McGaha, Ben Wang, Marcus Butler, Cynthia J. Guidos, Pam S. Ohashi, Lillian L. Siu, David G. Brooks

FRONTIERS IN ONCOLOGY (2019)

Article Multidisciplinary Sciences

Chronic virus infection drives CD8 T cell-mediated thymic destruction and impaired negative selection

Heidi J. Elsaesser, Mahmood Mohtashami, Ivan Osokine, Laura M. Snell, Cameron R. Cunningham, Giselle M. Boukhaled, Dorian B. McGavern, Juan Carlos Zuniga-Pflucker, David G. Brooks

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Immunology

GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment

Marie Jo Halaby, Kebria Hezaveh, Sara Lamorte, M. Teresa Ciudad, Andreas Kloetgen, Bethany L. MacLeod, Mengdi Guo, Ankur Chakravarthy, Tiago Da Silva Medina, Stefano Ugel, Aristotelis Tsirigos, Vincenzo Bronte, David H. Munn, Trevor J. Pugh, Daniel D. De Carvalho, Marcus O. Butler, Pamela S. Ohashi, David G. Brooks, Tracy L. McGaha

SCIENCE IMMUNOLOGY (2019)

Article Immunology

A network of immune and microbial modifications underlies viral persistence in the gastrointestinal tract

Bethany L. Macleod, Heidi J. Elsaesser, Laura M. Snell, Russell J. Dickson, Mengdi Guo, Kebria Hezaveh, Wenxi Xu, Akash Kothari, Tracy L. McGaha, Cynthia J. Guidos, David G. Brooks

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

DNA hypomethylating agents increase activation and cytolytic activity of CD8+T cells

Helen Loo Yau, Emma Bell, Ilias Ettayebi, Felipe Campos de Almeida, Giselle M. Boukhaled, Shu Yi Shen, David Allard, Beatriz Morancho, Sajid A. Marhon, Charles A. Ishak, Isabela M. Gonzaga, Tiago da Silva Medina, Rajat Singhania, Ankur Chakravarthy, Raymond Chen, Parinaz Mehdipour, Sandra Pommey, Christian Klein, Gustavo P. Amarante-Mendes, David Roulois, Joaquin Arribas, John Stagg, David G. Brooks, Daniel D. De Carvalho

Summary: The study demonstrates that DNA hypomethylating agents directly modulate the anti-tumor response and effector function of CD8(+) T cells, promoting tumor infiltration and suppressing growth. This effect is achieved through the regulation of T cell activation-related transcriptional networks, ultimately enhancing the immune response against tumors.

MOLECULAR CELL (2021)

Article Virology

Prevention of CD8 T Cell Deletion during Chronic Viral Infection

David G. Brooks, Antoinette Tishon, Michael B. A. Oldstone, Dorian B. McGavern

Summary: During chronic viral infections, CD8 T cells can rapidly lose antiviral and immune-stimulatory functions and be physically deleted, but therapeutic strategies such as lowering viral replication and utilizing CD4 T cell help can prevent CD8 T cell deletion and enhance their diversity and function.

VIRUSES-BASEL (2021)

Article Immunology

Dynamic CD4(+) T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection

Laura M. Snell, Wenxi Xu, Diala Abd-Rabbo, Giselle Boukhaled, Mengdi Guo, Bethany L. Macleod, Heidi J. Elsaesser, Kebria Hezaveh, Nirmin Alsahafi, Sabelo Lukhele, Sara Nejat, Ramanandan Prabhakaran, Slava Epelman, Tracy L. McGaha, David G. Brooks

Summary: Inhibiting PD-1:PD-L1 signaling can restore the immune function of CD4(+) T cells in chronic infections and modulate the activation of T regulatory cells. This study demonstrates the heterogeneity of CD4(+) T cells in chronic viral infection and shows that PD-L1 blockade can enhance cytotoxic gene programs in antigen-specific T(H)1 cells.

NATURE IMMUNOLOGY (2021)

Editorial Material Immunology

CD4+ progenitor cells sustain helper responses during chronic infection

Laura M. Snell

Summary: This study reveals a progenitor T cell subset that plays a crucial role in maintaining immune responses during chronic infection by generating effector and follicular helper T cells.

IMMUNITY (2022)

Article Immunology

The transcription factor IRF2 drives interferon-mediated CD8+T cell exhaustion to restrict anti-tumor immunity

Sabelo Lukhele, Diala Abd Rabbo, Mengdi Guo, Jian Shen, Heidi J. Elsaesser, Rene Quevedo, Madeleine Carew, Ramy Gadalla, Laura M. Snell, Lawanya Mahesh, M. Teresa Ciudad, Bryan E. Snow, Annick You-Ten, Jillian Haight, Andrew Wakeham, Pamela S. Ohashi, Tak W. Mak, Weiguo Cui, Tracy L. McGaha, David G. Brooks

Summary: Type I and II interferons stimulate pro-inflammatory programs critical for immune activation, but also induce immune-suppressive feedback circuits that hinder cancer control. This study reveals that the transcription factor IRF2 plays a key role in redirecting interferon signals to suppress T cell responses and prevent T cell exhaustion within the tumor microenvironment, leading to improved tumor control and increased responsiveness to immune therapies.

IMMUNITY (2022)

Article Medicine, Research & Experimental

CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection

Vyacheslav Palchevskiy, Ying Ving Xue, Rita Kern, Stephen S. Weigt, Ark L. Gregson, Sophie X. Song, Michael C. Fishbein, Cory M. Hogaboam, David M. Sayah, Joseph P. Lynch, Michael P. Keane, David G. Brooks, John A. Belperio

JCI INSIGHT (2019)

暂无数据